4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002562
Director bought 2,500 shares at $1.70 ($4,250)
From the SEC's structured data for this filing
Trades in this filing
Gumulka Jerzy · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-19 | Purchase : show line 1 in the form | +2,500 | $1.70 | $4,250 | 9,673 | D |
| Open-market purchases · 2,500 sh · avg $1.70 · $4,250 | ||||||
Loading xslF345X04/ownership.xml…